# Birchtech Corp.: overview BCHT · NYSE · CIK 728385 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bcht.md) · [Financials](/companies/bcht/financials.md) · [Filings](/companies/bcht/filings.md) · [Insiders](/companies/bcht/insiders.md) Latest reported revenue: [$3.8m](/filings/0001477932-26-004988.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001477932-26-004988). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [5,237](/filings/0001477932-25-008185.md) | [5,566 d](/filings/0001477932-26-001835.md) | [3,221](/filings/0001477932-26-003054.md) | [3,254](/filings/0001477932-26-004988.md) | [7,362](/filings/0001477932-25-008185.md) | [3,790 d](/filings/0001477932-26-001835.md) | [4,240](/filings/0001477932-26-003054.md) | [3,791](/filings/0001477932-26-004988.md) | | Gross margin | % | [30.5%](/filings/0001477932-25-008185.md) | [59.6% d](/filings/0001477932-26-001835.md) | [38.3%](/filings/0001477932-26-003054.md) | [29.8%](/filings/0001477932-26-004988.md) | [54.8%](/filings/0001477932-25-008185.md) | [30.8% d](/filings/0001477932-26-001835.md) | [32.6%](/filings/0001477932-26-003054.md) | [27.2%](/filings/0001477932-26-004988.md) | | Operating margin | % | [(21.1%)](/filings/0001477932-25-008185.md) | [(1.4%) d](/filings/0001477932-26-001835.md) | [(41.7%)](/filings/0001477932-26-003054.md) | [(36.4%)](/filings/0001477932-26-004988.md) | [11.0%](/filings/0001477932-25-008185.md) | [(34.6%) d](/filings/0001477932-26-001835.md) | [(27.1%)](/filings/0001477932-26-003054.md) | [(42.8%)](/filings/0001477932-26-004988.md) | | Net margin | % | [(8.7%)](/filings/0001477932-25-008185.md) | [(24.1%) d](/filings/0001477932-26-001835.md) | [(52.1%)](/filings/0001477932-26-004988.md) | [(47.4%)](/filings/0001477932-26-004988.md) | [10.7%](/filings/0001477932-25-008185.md) | [(15.6%) d](/filings/0001477932-26-001835.md) | [(31.7%)](/filings/0001477932-26-004988.md) | [(79.6%)](/filings/0001477932-26-004988.md) | | Diluted EPS | $ per share | [0.00](/filings/0001477932-25-008185.md) | not reported | [(0.09)](/filings/0001477932-26-003054.md) | [(0.08)](/filings/0001477932-26-004988.md) | [0.01](/filings/0001477932-25-008185.md) | not reported | [(0.06)](/filings/0001477932-26-003054.md) | [(0.11)](/filings/0001477932-26-004988.md) | | Free cash flow | $k | [(788) d](/filings/0001477932-25-008185.md) | [(938) d](/filings/0001477932-26-001835.md) | [(268)](/filings/0001477932-26-003054.md) | [(1,734) d](/filings/0001477932-26-004988.md) | [314 d](/filings/0001477932-25-008185.md) | [958 d](/filings/0001477932-26-001835.md) | [(2,207)](/filings/0001477932-26-003054.md) | [(2,912) d](/filings/0001477932-26-004988.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [13.0](/filings/0001477932-23-003370.md) | [21.6](/filings/0001477932-24-002170.md) | [17.6](/filings/0001477932-25-002237.md) | [17.4](/filings/0001477932-26-001835.md) | [17.6](/filings/0001477932-26-001835.md) | | Gross margin | % | not reported | [32.5%](/filings/0001477932-24-002170.md) | [30.9%](/filings/0001477932-25-002237.md) | [40.8%](/filings/0001477932-26-001835.md) | [42.0%](/filings/0001477932-26-001835.md) | | Operating margin | % | not reported | [4.2%](/filings/0001477932-24-002170.md) | [(50.9%)](/filings/0001477932-25-002237.md) | [(41.1%)](/filings/0001477932-26-001835.md) | [(17.2%)](/filings/0001477932-26-001835.md) | | Net margin | % | [(27.9%)](/filings/0001477932-23-003370.md) | [(7.3%)](/filings/0001477932-24-002170.md) | [32.2%](/filings/0001477932-25-002237.md) | [(62.1%)](/filings/0001477932-26-001835.md) | [(17.2%)](/filings/0001477932-26-001835.md) | | Diluted EPS | $ per share | not reported | [(0.02)](/filings/0001477932-24-002170.md) | [0.06](/filings/0001477932-25-002237.md) | [(0.57)](/filings/0001477932-26-001835.md) | [(0.16)](/filings/0001477932-26-001835.md) | | Free cash flow | $m | [(0.2)](/filings/0001477932-23-003370.md) | [0.1](/filings/0001477932-24-002170.md) | [19.2](/filings/0001477932-25-002237.md) | [(4.9)](/filings/0001477932-26-001835.md) | [(0.7)](/filings/0001477932-26-001835.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Gross profit: us-gaap:GrossProfit. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bcht/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [HEARTLAND ADVISORS INC](/funds/937394.md) | 2026-06-30 | $2.0m | 1,000,000 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.5m | 721,182 | | New +721,182 | | [Ancora Advisors LLC](/funds/1446114.md) | 2026-06-30 | $1.4m | 700,244 | | Added +271,558 | | [CHAPIN DAVIS, INC.](/funds/872098.md) | 2026-06-30 | $1.4m | 686,693 | | Unchanged | | [Aristides Capital LLC](/funds/1595521.md) | 2026-06-30 | $871.3k | 425,000 | | Unchanged | | [WHITE PINE CAPITAL LLC](/funds/1137429.md) | 2026-06-30 | $676.8k | 330,154 | | Added +40,981 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $285.3k | 139,192 | | New +139,192 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $212.5k | 103,667 | | New +103,667 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $146.1k | 71,250 | | New +71,250 | | [ARS Investment Partners, LLC](/funds/733020.md) | 2026-06-30 | $131.6k | 64,200 | | Added +13,100 | ## Recent filings [All 629 filings](/companies/bcht/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-13 | 20:16 ET | [10-Q](/filings/0001477932-26-004988.md) | Quarterly report, period 2026-06-30 | 0001477932-26-004988 | | 2026-07-28 | 20:30 ET | [8-K](/filings/0001477932-26-004563.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-26-004563 | | 2026-06-24 | 11:30 ET | [DEF 14A](/filings/0001477932-26-003963.md) | Proxy statement, period 2026-07-23 | 0001477932-26-003963 | | 2026-05-13 | 20:16 ET | [10-Q](/filings/0001477932-26-003054.md) | Quarterly report, period 2026-03-31 | 0001477932-26-003054 | | 2026-05-12 | 20:16 ET | [8-K/A](/filings/0001477932-26-002995.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-26-002995 | | 2026-05-06 | 20:15 ET | [8-K](/filings/0001477932-26-002802.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-26-002802 | | 2026-04-13 | 20:15 ET | [8-K](/filings/0001477932-26-002165.md) | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-002165 | | 2026-03-31 | 20:15 ET | [10-K](/filings/0001477932-26-001835.md) | Annual report, period 2025-12-31 | 0001477932-26-001835 | | 2026-03-17 | 20:05 ET | [8-K](/filings/0001104659-26-029450.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-029450 | | 2026-02-27 | 21:01 ET | [8-K](/filings/0001104659-26-021534.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-021534 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001477932-26-001835.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f61ec5cc-691d-46cd-aef1-270a63d1eadf) ## About the filer - CIK: 728385 - Tickers: BCHT - Exchange: NYSE - SIC code: 3829 Measuring & Controlling Devices, NEC - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.